NeuroPace Inc (NPCE) shareholders
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3013% above fair value
$7.56−4.46 (-37.10%)
Close on Nov 13, 2026Market cap $259.49MP/E –Yield 0.00%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
77.4%
27M of 34M shares
Institutional holders
113
19 new, 18 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 1 sales
Net sold $399.25K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Mathew P. Arens Joint filing with First Light Asset Management, LLC (11.78%) | 4,203,931 | 12.25% | 13G (passive) amendment | Aug 31, 2026 |
| Polar Capital LLP Joint filing with Polar Capital Holdings Plc (9.13%) | 2,972,003 | 9.13% | 13G (passive) | Mar 31, 2025 |
| Guy Levy Joint filing with Soleus Capital Management, L.P. (8.90%), Soleus GP, LLC (8.90%) and 3 more | 2,957,957 | 8.90% | 13G (passive) amendment | Sep 30, 2025 |
| Morgan Stanley Joint filing with Morgan Stanley Capital Services LLC (8.20%) | 2,489,391 | 8.30% | 13G (passive) amendment | Dec 31, 2024 |
| OrbiMed Capital GP VI LLC Joint filing with OrbiMed Advisors LLC (6.20%) | 2,096,527 | 6.20% | 13G (passive) amendment | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NPCE | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc | 3,298,104 | 9.61% | $52.41M | – | 0.12% |
| Soleus Capital Management, L.P. | 2,911,122 | 8.48% | $46.26M | −21,085 | 1.59% |
| First Light Asset Management, LLC | 2,861,167 | 8.34% | $45.46M | +401,201 | 2.76% |
| Morgan Stanley | 2,654,391 | 7.73% | $42.18M | +87,552 | 0.00% |
| BlackRock, Inc. | 2,477,603 | 7.22% | $39.37M | +131,270 | 0.00% |
| Orbimed Advisors LLC | 1,505,125 | 4.39% | $23.92M | −591,402 | 0.44% |
| Driehaus Capital Management LLC | 1,447,391 | 4.22% | $23.00M | −4,220 | 0.13% |
| Vanguard Capital Management LLC | 1,227,072 | 3.57% | $19.50M | +103,361 | 0.00% |
| Deutsche Bank AG\ | 938,919 | 2.74% | $14.92M | +6,829 | 0.00% |
| Armistice Capital, LLC | 692,000 | 2.02% | $11.00M | – | 0.13% |
| Geode Capital Management, LLC | 666,300 | 1.94% | $10.59M | +48,181 | 0.00% |
| FMR LLC | 554,771 | 1.62% | $8.82M | +1,242 | 0.00% |
| State Street Corp | 550,132 | 1.60% | $8.74M | +52,586 | 0.00% |
| Silvercrest Asset Management Group LLC | 344,124 | 1.00% | $5.47M | −15,941 | 0.04% |
| Northern Trust Corp | 260,025 | 0.76% | $4.13M | +20,185 | 0.00% |
| Qube Research & Technologies Ltd | 221,237 | 0.64% | $3.52M | +35,048 | 0.00% |
| Vanguard Portfolio Management LLC | 220,371 | 0.64% | $3.50M | +32,942 | 0.00% |
| Palumbo Wealth Management LLC | 209,199 | 0.61% | $3.32M | −1,270 | 0.70% |
| Essex Investment Management Co LLC | 208,703 | 0.61% | $3.32M | −9,035 | 0.43% |
| Algert Global LLC | 184,774 | 0.54% | $2.94M | +5,218 | 0.03% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 113 | 27M | 77.4% | 19 / 48 | 36 / 18 | 2M | 1M |
| Q1 2026 | 113 | 26M | 77.1% | 28 / 39 | 36 / 13 | 4M | 2M |
| Q4 2025 | 100 | 26M | 76.7% | 26 / 38 | 29 / 4 | 3M | 2M |
| Q3 2025 | 80 | 26M | 75.6% | 10 / 34 | 20 / 28 | 5M | 2M |
| Q2 2025 | 98 | 23M | 65.6% | 21 / 46 | 23 / 13 | 4M | 6M |
| Q1 2025 | 90 | 24M | 69.7% | 35 / 28 | 15 / 6 | 10M | 7M |
| Q4 2024 | 62 | 21M | 60.8% | 18 / 21 | 10 / 4 | 6M | 0M |
| Q3 2024 | 48 | 15M | 43.1% | 8 / 16 | 14 / 9 | 3M | 1M |
| Q2 2024 | 51 | 15M | 43.9% | 18 / 17 | 13 / 21 | 3M | 7M |
| Q1 2024 | 54 | 18M | 53.5% | 18 / 20 | 12 / 5 | 4M | 2M |
| Q4 2023 | 41 | 16M | 47.6% | 18 / 15 | 7 / 1 | 4M | 0M |
| Q3 2023 | 25 | 18M | 52.7% | 5 / 10 | 5 / 1 | 2M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
113 funds held NPCE in Q2 2026, 50% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NPCE | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 908,479 | 2.65% | $14.44M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 688,652 | 2.01% | $10.94M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 290,400 | 0.85% | $4.61M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 288,065 | 0.84% | $3.71M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 248,901 | 0.73% | $3.96M | 0.03% | Jun 30, 2026 |
| BlackRock Advantage Small Cap Core Fund | 227,093 | 0.66% | $3.76M | 0.07% | May 29, 2026 |
| Fidelity Small Cap Growth Fund | 209,986 | 0.61% | $2.71M | 0.03% | Jul 31, 2026 |
| Driehaus Micro Cap Growth Fund | 175,099 | 0.51% | $2.78M | 0.47% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 131,045 | 0.38% | $2.17M | 0.01% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 126,017 | 0.37% | $2.08M | 0.00% | May 31, 2026 |
| Fidelity Small Cap Growth K6 Fund | 108,032 | 0.31% | $1.39M | 0.03% | Jul 31, 2026 |
| North Square Dynamic Small Cap Fund | 91,663 | 0.27% | $1.52M | 0.19% | May 31, 2026 |
| iShares Micro-Cap ETF | 89,094 | 0.26% | $1.42M | 0.09% | Jun 30, 2026 |
| Adara Smaller Companies Fund | 85,121 | 0.25% | $1.41M | 0.17% | May 31, 2026 |
| Schwab Small-Cap Index Fund | 64,471 | 0.19% | $831.03K | 0.01% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joel Becker | CHIEF EXECUTIVE OFFICER, Director | 138,000 | 0.40% | Sep 4, 2026 |
| Martha Morrell | CHIEF MEDICAL OFFICER | 51,357 | 0.15% | Sep 25, 2026 |
| Patrick F. Williams | Chief Financial Officer | 67,508 | 0.20% | Sep 21, 2026 |
| Rebecca Kuhn | CHIEF FINANCIAL OFFICER | 131,613 | 0.38% | Jun 6, 2025 |
| Uri Geiger | Director | 4,451,485 | 12.97% | Jun 22, 2026 |
| Rakhi Kumar | Director | 23,039 | 0.07% | Jun 22, 2026 |
| Frank M. Fischer | Director | 599,534 | 1.75% | Jun 22, 2026 |
| R. Scott Huennekens | Director | 2,890 | 0.01% | Jun 5, 2026 |
| Renee Ryan | Director | 2,890 | 0.01% | Jun 5, 2026 |
| Lisa Andrade | Director | 2,890 | 0.01% | Jun 5, 2026 |
| Joseph Lacob | Director | 238,308 | 0.69% | Mar 24, 2026 |
| Advisors Llc Orbimed | 10% owner | 3,272,199 | 9.53% | May 16, 2025 |
| Capital GP VI LLC OrbiMed | 10% owner | 3,501,975 | 10.20% | May 16, 2025 |
| Ltd. Kck | 10% owner | 0 | – | Feb 20, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Martha Morrell CHIEF MEDICAL OFFICER | Sep 24, 2026 | Tax withholding | −335 | $13.97 | $4.68K | 51,357 |
| Patrick F. Williams Chief Financial Officer | Sep 20, 2026 | Tax withholding | −1,162 | $14.28 | $16.59K | 67,508 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Sep 3, 2026 | Tax withholding | −1,310 | $14.75 | $19.32K | 138,000 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Aug 27, 2026 | Tax withholding | −1,126 | $14.13 | $15.91K | 139,310 |
| Martha Morrell CHIEF MEDICAL OFFICER | Aug 27, 2026 | Tax withholding | −358 | $14.13 | $5.06K | 51,692 |
| Martha Morrell CHIEF MEDICAL OFFICER | Jun 24, 2026 | Tax withholding | −335 | $16.22 | $5.43K | 52,050 |
| Rakhi Kumar Director | Jun 19, 2026 | Award | +989 | $15.63 | $15.46K | 23,039 |
| Frank M. Fischer Director | Jun 19, 2026 | Award | +1,467 | $15.63 | $22.93K | 599,534 |
| Uri Geiger Director | Jun 19, 2026 | Award | +789 | $15.63 | $12.33K | 18,537 |
| Frank M. Fischer Director | Jun 5, 2026 | Award | +2,890 | – | – | 598,067 |
| Lisa Andrade Director | Jun 5, 2026 | Award | +2,890 | – | – | 2,890 |
| Uri Geiger Director | Jun 5, 2026 | Award | +2,890 | – | – | 17,748 |
| Rakhi Kumar Director | Jun 5, 2026 | Award | +2,890 | – | – | 22,050 |
| R. Scott Huennekens Director | Jun 5, 2026 | Award | +2,890 | – | – | 2,890 |
| Renee Ryan Director | Jun 5, 2026 | Award | +2,890 | – | – | 2,890 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Jun 3, 2026 | Tax withholding | −1,255 | $15.88 | $19.93K | 140,436 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | May 27, 2026 | Tax withholding | −1,126 | $17.06 | $19.21K | 141,691 |
| Martha Morrell CHIEF MEDICAL OFFICER | May 27, 2026 | Tax withholding | −358 | $17.06 | $6.11K | 52,385 |
| Martha Morrell CHIEF MEDICAL OFFICER | May 15, 2026 | Award | +5,460 | – | – | 52,743 |
| Patrick F. Williams Chief Financial Officer | May 15, 2026 | Award | +16,820 | – | – | 68,670 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | May 15, 2026 | Award | +45,880 | – | – | 142,817 |
| Martha Morrell CHIEF MEDICAL OFFICER | Mar 24, 2026 | Tax withholding | −1,341 | $13.27 | $17.80K | 47,283 |
| Joseph Lacob Director | Mar 20, 2026 | Award | +865 | $13.00 | $11.25K | 14,754 |
| Uri Geiger Director | Mar 20, 2026 | Award | +913 | $13.00 | $11.87K | 14,858 |
| Frank M. Fischer Director | Mar 20, 2026 | Award | +1,826 | $13.00 | $23.74K | 595,177 |
| Rakhi Kumar Director | Mar 20, 2026 | Award | +1,153 | $13.00 | $14.99K | 19,160 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Mar 3, 2026 | Tax withholding | −5,023 | $13.83 | $69.47K | 96,937 |
| Martha Morrell CHIEF MEDICAL OFFICER | Mar 3, 2026 | Tax withholding | −1,340 | $13.83 | $18.53K | 48,624 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Feb 27, 2026 | Tax withholding | −1,126 | $14.58 | $16.42K | 101,960 |
| Martha Morrell CHIEF MEDICAL OFFICER | Feb 27, 2026 | Tax withholding | −358 | $14.58 | $5.22K | 74,964 |
| Martha Morrell CHIEF MEDICAL OFFICER | Feb 20, 2026 | Tax withholding | −3,412 | $14.34 | $48.93K | 75,322 |
| Uri Geiger Director | Dec 19, 2025 | Award | +715 | $16.59 | $11.86K | 13,945 |
| Rakhi Kumar Director | Dec 19, 2025 | Award | +904 | $16.59 | $15.00K | 18,007 |
| Frank M. Fischer Director | Dec 19, 2025 | Award | +1,431 | $16.59 | $23.74K | 593,351 |
| Joseph Lacob Director | Dec 19, 2025 | Award | +678 | $16.59 | $11.25K | 13,889 |
| Martha Morrell CHIEF MEDICAL OFFICER | Dec 15, 2025 | Sale(10b5-1 plan) | −25,000 | $15.97 | $399.25K | 49,964 |
| Martha Morrell CHIEF MEDICAL OFFICER | Dec 3, 2025 | Tax withholding | −1,338 | $16.66 | $22.29K | 78,734 |
| Martha Morrell CHIEF MEDICAL OFFICER | Nov 27, 2025 | Tax withholding | −357 | $16.50 | $5.89K | 80,072 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Nov 27, 2025 | Tax withholding | −1,126 | $16.50 | $18.58K | 103,086 |
| Martha Morrell CHIEF MEDICAL OFFICER | Nov 20, 2025 | Tax withholding | −3,051 | $13.50 | $41.19K | 80,429 |
| Frank M. Fischer Director | Sep 19, 2025 | Award | +2,389 | $9.94 | $23.75K | 591,920 |
| Joseph Lacob Director | Sep 19, 2025 | Award | +1,131 | $9.94 | $11.24K | 13,211 |
| Rakhi Kumar Director | Sep 19, 2025 | Award | +1,509 | $9.94 | $15.00K | 17,103 |
| Uri Geiger Director | Sep 19, 2025 | Award | +1,194 | $9.94 | $11.87K | 13,230 |
| Martha Morrell CHIEF MEDICAL OFFICER | Sep 3, 2025 | Tax withholding | −1,337 | $9.36 | $12.51K | 83,480 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | Aug 27, 2025 | Tax withholding | −1,126 | $8.88 | $10.00K | 104,212 |
| Martha Morrell CHIEF MEDICAL OFFICER | Aug 27, 2025 | Tax withholding | −357 | $8.88 | $3.17K | 84,817 |
| Martha Morrell CHIEF MEDICAL OFFICER | Aug 20, 2025 | Tax withholding | −3,052 | $8.66 | $26.43K | 85,174 |
| Uri Geiger Director | Jun 21, 2025 | Award | +1,140 | $10.41 | $11.87K | 12,036 |
| Joseph Lacob Director | Jun 21, 2025 | Award | +1,080 | $10.41 | $11.24K | 12,080 |
| Frank M. Fischer Director | Jun 21, 2025 | Award | +2,281 | $10.41 | $23.75K | 589,531 |
| Rakhi Kumar Director | Jun 21, 2025 | Award | +1,440 | $10.41 | $14.99K | 15,594 |
| Patrick F. Williams Chief Financial Officer | Jun 20, 2025 | Award | +51,850 | – | – | 51,850 |
| Martha Morrell CHIEF MEDICAL OFFICER | Jun 3, 2025 | Tax withholding | −1,338 | $13.54 | $18.12K | 85,943 |
| Rebecca Kuhn CHIEF FINANCIAL OFFICER | Jun 3, 2025 | Tax withholding | −1,337 | $13.54 | $18.10K | 131,613 |
| Martha Morrell CHIEF MEDICAL OFFICER | May 27, 2025 | Tax withholding | −357 | $12.66 | $4.52K | 87,281 |
| Joel Becker CHIEF EXECUTIVE OFFICER, Director | May 27, 2025 | Tax withholding | −1,126 | $12.66 | $14.26K | 105,338 |
| Rebecca Kuhn CHIEF FINANCIAL OFFICER | May 27, 2025 | Tax withholding | −357 | $12.66 | $4.52K | 132,950 |
| Rebecca Kuhn CHIEF FINANCIAL OFFICER | May 20, 2025 | Tax withholding | −3,051 | $17.99 | $54.89K | 133,307 |
| Martha Morrell CHIEF MEDICAL OFFICER | May 20, 2025 | Tax withholding | −3,051 | $17.99 | $54.89K | 87,638 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
3.00%
1M shares short
Days to cover
8.5
At 0M shares a day
Change since last report
-3.1%
From 1M shares
Short volume, 20 days
56.7%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of NeuroPace's stock actually held short. Settlement fails (shares not delivered on time) peaked at 531 shares on Sep 18, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Martha Morrell Officer | Dec 15, 2025 | 25,000 | $404.75K | Dec 15, 2025 | Restricted Stock Units |
| Martha Morrell Officer | Jan 30, 2025 | 78,534 | $1.15M | Jan 30, 2025 | Employee Stock Purchase Plan |
| Martha Morrell Officer | Jan 29, 2025 | 100 | $1.41K | Jan 29, 2025 | Employee Stock Purchase Plan |
| Martha Morrell Officer | Jan 24, 2025 | 3,200 | $44.86K | Jan 24, 2025 | Employee Stock Purchase Plan |
| Ltd. Kck 10% Stockholder | Oct 28, 2024 | 223,991 | $1.22M | Oct 25, 2024 | Automatic Conversion of Preferred Stock at Issuer's IPO |
| Ltd. Kck 10% Stockholder | Oct 3, 2024 | 190,000 | $1.47M | Aug 30, 2024 | Automatic Conversion of Preferred Stock at Issuer's IPO |
| Irina Ridley Chief Legal Officer | Mar 15, 2024 | 3,936 | $53.63K | Mar 15, 2024 | ESPP |
| Martha Morrell Chief Medical Officer | Dec 20, 2023 | 48,397 | $483.49K | Dec 20, 2023 | Stock Option Exercise |
| Martha Morrell Affiliate | Dec 6, 2023 | 11,005 | $89.77K | Dec 6, 2023 | ESPP |
| Ltd. Kck Shareholder | Nov 29, 2023 | 262,836 | $2.30M | Nov 27, 2023 | Automatic Conversion of Preferred Stock at Issuer's IPO |
| OrbiMed Private Investments VI, LP Shareholder | Oct 2, 2023 | 288,100 | $2.56M | Oct 2, 2023 | IPO |
See a number that looks wrong?